J. Louwerenburg

发表

Patient preference regarding assessment of clinical follow-up after percutaneous coronary intervention: the PAPAYA study.

Maarten J. IJzerman, J. W. Louwerenburg, M. Stoel, 2016, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Very thin strut biodegradable polymer everolimus-eluting and sirolimus-eluting stents versus durable polymer zotarolimus-eluting stents in allcomers with coronary artery disease (BIO-RESORT): a three-arm, randomised, non-inferiority trial

J. W. Louwerenburg, M. Stoel, G. Linssen, 2016, The Lancet.

A randomized controlled trial in second-generation zotarolimus-eluting Resolute stents versus everolimus-eluting Xience V stents in real-world patients: the TWENTE trial.

J. W. Louwerenburg, M. Stoel, C. von Birgelen, 2012, Journal of the American College of Cardiology.

Clinical outcome following second-generation drug-eluting stent use for off-label versus on-label indications: insights from the two-year outcome of the TWENTE trial.

J. W. Louwerenburg, M. Stoel, C. von Birgelen, 2014, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Complex patients treated with zotarolimus‐eluting resolute and everolimus‐eluting xience V stents in the randomized TWENTE trial: Comparison of 2‐year clinical outcome

J. W. Louwerenburg, M. Stoel, F. H. Man, 2015, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

CORONARY INTERVENT IONS

J. W. Louwerenburg, M. Stoel, G. Linssen, 2014 .

Women treated with second‐generation zotarolimus‐eluting resolute stents and everolimus‐eluting xience V stents: insights from the gender‐stratified, randomized, controlled TWENTE trial

J. W. Louwerenburg, M. Stoel, F. H. Man, 2013, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

5-Year Outcome Following Randomized Treatment of All-Comers With Zotarolimus-Eluting Resolute Integrity and Everolimus-Eluting PROMUS Element Coronary Stents: Final Report of the DUTCH PEERS (TWENTE II) Trial.

J. W. Louwerenburg, M. Stoel, C. von Birgelen, 2018, JACC. Cardiovascular interventions.

Long-term outcome and chest pain in patients with true versus non-true bifurcation lesions treated with second-generation drug-eluting stents in the TWENTE trial

Maarten J. IJzerman, J. W. Louwerenburg, C. von Birgelen, 2016, Heart and Vessels.

Third-generation zotarolimus-eluting and everolimus-eluting stents in all-comer patients requiring a percutaneous coronary intervention (DUTCH PEERS): a randomised, single-blind, multicentre, non-inferiority trial

J. W. Louwerenburg, M. Stoel, C. von Birgelen, 2014, The Lancet.

Sex Difference in Chest Pain After Implantation of Newer Generation Coronary Drug-Eluting Stents: A Patient-Level Pooled Analysis From the TWENTE and DUTCH PEERS Trials.

Maarten J. IJzerman, J. W. Louwerenburg, A. Maas, 2016, JACC. Cardiovascular interventions.

Three‐year clinical outcome after treatment of chronic total occlusions with second‐generation drug‐eluting stents in the TWENTE trial

J. W. Louwerenburg, M. Stoel, C. von Birgelen, 2015, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Clopidogrel or ticagrelor in acute coronary syndrome patients treated with newer-generation drug-eluting stents: CHANGE DAPT.

J. W. Louwerenburg, M. Stoel, I. Knottnerus, 2017, EuroIntervention.

High bleeding risk patients with acute coronary syndromes treated with contemporary drug-eluting stents and Clopidogrel or Ticagrelor: Insights from CHANGE DAPT.

J. W. Louwerenburg, M. Stoel, I. Knottnerus, 2018, International journal of cardiology.

Comparison of frequency of periprocedural myocardial infarction in patients with and without diabetes mellitus to those with previously unknown but elevated glycated hemoglobin levels (from the TWENTE Trial).

J. W. Louwerenburg, M. Stoel, R. Stolk, 2012, The American journal of cardiology.